Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CES2 | O00748 | 3/20 | 0.36 |
| ▸ | CES1 | P23141 | 3/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9248456 | 1.00 | — | — | |
| SCHEMBL29074323 | 1.00 | TSHR (0.44) | TSHRTHRBALDH1A1CES2CES1 | |
| SCHEMBL27033085 | 1.00 | TSHR (0.44) | TSHRTHRBALDH1A1CES2CES1 | |
| SCHEMBL6364555 | 1.00 | TSHR (0.44) | TSHRTHRBALDH1A1CES2CES1 | |
| SCHEMBL1616141 | 0.97 | — | — | |
| SCHEMBL2901647 | 0.88 | — | — | |
| SCHEMBL8814930 | 0.82 | — | — | |
| Hexane SCHEMBL7134957 | 0.78 | TSHR (0.50) | TSHRTHRBALDH1A1CES2CES1 | |
| SCHEMBL10866350 | 0.78 | TSHR (0.44) | TSHRTHRBALDH1A1CES2CES1 | |
| SCHEMBL11880617 | 0.78 | TSHR (0.44) | TSHRTHRBALDH1A1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117222414-A | Compounds for activating constant natural killer T-cells and methods for eliminating inflammatory senescent cells | 脱落性治疗公司 | 2023-12-12 | — | — | CN | disclosed |